A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To investigate the dose response in respect of weight decrease following repeated oral administration of OPC-131461 at 1, 2, 5, and 10 mg or placebo in patients with CHF with volume overload despite having received diuretics other than vasopressin antagonists
Epistemonikos ID: 836ceaa4442d2175f16e5910a5aaa1205529da43
First added on: May 14, 2024